May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
VEGF-Mediated Blood-Retinal Barrier Breakdown in Experimental Models of Diabetic Retinopathy Is Closely Linked to Renin-Angiotensin System
Author Affiliations & Notes
  • S. Jeong
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • Y. S. Yu
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Seoul National University Hospital, Seoul, Republic of Korea
  • K.-H. Park
    Ophthalmology, Bundang Seoul National University Hospital, Seoul, Republic of Korea
  • J. Kim
    Division of Pharmaceutical Bioscience, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
  • K.-W. Kim
    Division of Pharmaceutical Bioscience, College of Pharmacy, Seoul National University, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships S. Jeong, None; Y.S. Yu, None; J. Kim, None; K. Park, None; J. Kim, None; K. Kim, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4972. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Jeong, Y. S. Yu, J. Kim, K.-H. Park, J. Kim, K.-W. Kim; VEGF-Mediated Blood-Retinal Barrier Breakdown in Experimental Models of Diabetic Retinopathy Is Closely Linked to Renin-Angiotensin System. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4972.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: To evaluate the coordinated action of renin-angiotensin system and vasopermeable factor on blood-retinal barrier breakdown of diabetic retinopathy

Methods:: In experimental mice models of diabetic retinopathy with or without intravitreal injection of ACE inhibitor, retinal vascular leakage was evaluated through intravenous injection of FITC-dextran. Expression of angiotensin II (ANG II), angiotensin II receptor type 1 (ATR1) & 2 (ATR2), and VEGF were evaluated by immunohistochemistry and Western blotting. Tight junction proteins such as ZO-1, ZO-2, and occludin were checked as well. In Human retinal endothelial cell (HREC), VEGF-induced tight junction protein expression was measured with or without ACE inhibitor treatment

Results:: With ACE inhibitor, retinal vascular leakage was blocked, which was followed by decrease of ANG II, ATR1, ATR2, and VEGF expression and recovery of tight junction protein expression in the retina of diabetic mice. Also, VEGF-induced decrease of tight junction proteins was blocked by ACE inhibitor.

Conclusions:: Our data suggests that blockade of the renin-angiotensin system can confer the prevention of VEGF mediated blood-retinal barrier breakdown in experimental models of diabetic retinopathy.

Keywords: diabetic retinopathy • vascular occlusion/vascular occlusive disease • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×